We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Judges Scientific Plc | LSE:JDG | London | Ordinary Share | GB0032398678 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10,900.00 | 10,850.00 | 11,100.00 | 10,975.00 | 10,900.00 | 10,900.00 | 2,996 | 16:35:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Lab Analytical Instruments | 113.21M | 12.44M | 1.8823 | 58.31 | 725.2M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/10/2021 17:28 | Four hours talking about stocks ; I think I'll go and wash my hair :-) | wad collector | |
18/10/2021 16:53 | 'New all time high. What a great investment this has been, having first purchased in 2009 at a little over £1.' Agreed....Did you watch the interview? .It has just been released to our 800 plus annual pass holders and is available here... That is the whole four hour show. Next show is on the 8th November | davidosh | |
18/10/2021 16:44 | New all time high. What a great investment this has been, having first purchased in 2009 at a little over £1. | cornishman33 | |
18/10/2021 14:03 | Still, anyone who has bought a 50 bagger should be allowed to boast a little.... I'm on a paltry 30 percent. | wad collector | |
12/10/2021 10:23 | He has more sense than to tell you inside information so it's not really a secret is it. | constable ken | |
11/10/2021 15:57 | We've had over 300 companies present at Mello in the last 15 yrs but none as successful to date as Judges Scientific which has 50 bagged for investors since David Cicurel came to dinner in 2009 Tonight I interview him & discover the secret of his success | davidosh | |
01/10/2021 22:51 | A hold in IC this week @ 7500. | wad collector | |
28/9/2021 13:56 | Judges will be reviewed in the Mello September Results Review show tonight To join with a complimentary shareholder pass use code 2809Mello | davidosh | |
28/9/2021 09:07 | Judges Scientific plc (JDG) Interim results presentation September 2021 Judges’ CEO, David Cicurel, Gp FD, Brad Ormsby and COO, Mark Lavelle, present interim results for the period ended 30 June 2021. Watch the video here: Or listen to the podcast here: | tomps2 | |
24/9/2021 19:59 | Mr Hoop to you ;-) | cockerhoop | |
24/9/2021 17:13 | WHI upgraded around 10% to 208p which I think is still light considering the 18.8 week orderbook and a historic H2 weighting. | cockerhoop | |
24/9/2021 10:31 | Does anyone know what analysts’ estimates are, please? I was forecasting 190p for the year. | ymaheru | |
24/9/2021 09:09 | Despite obvious irritation at the obstacles created by Covid and supply chain issues etc, the outlook is positive as the chairman says "Our financial position is robust and the Board has confidence that the performance for the year as a whole will be ahead of consensus expectations." Just wish I had bought more when they were £6.33. Still mustn't grumble. | alter ego | |
24/9/2021 09:00 | A company that just keeps giving!!!! | jaf111 | |
31/8/2021 17:58 | That is an impressive chart with a new ATH. I wonder why? | wad collector | |
22/7/2021 09:19 | Great trading update | montynj | |
26/5/2021 13:06 | David Circuel has said he believes that having come through the financial crisis and now, Covid, many owners will be thinking about selling up before another crisis hits them. He doesn't think putting more resources into seeking deals would work as you can't persuade someone to retire so JDG will wait to be approached. Owners know JDG will look after the business and its employees which must be important if it's been your life's work. However, I suspect they have a number of irons in the fire, hence the improved finance available. | alter ego | |
26/5/2021 12:43 | Inference from this announcement is that the board believes there is scope to accelerate their acquisition strategy, but knowing their criteria is set in stone in terms of ratios it may be awhile before any new deals materialise. | grahamburn | |
26/5/2021 07:38 | New GBP60.0 million Bank Facility Judges Scientific, the group focused on acquiring and developing companies in the scientific instrument sector, is pleased to announce that it has entered into new banking facilities ("Facility") with Lloyds Banking Group plc (the "Bank") which replace its existing banking arrangements with the Bank, which were for an aggregate amount of GBP35.0 million. This new Facility will provide greater acquisition financing capacity, both in terms of higher frequency and/or larger deals, in support of the Group's buy and build strategy. The Facility is for an aggregate GBP60.0 million consisting of a GBP19.0 million term loan ("Term Loan"), a committed GBP35.0 million revolving credit facility ("RCF") plus a GBP6.0 million accordion facility, which can be drawn at the discretion of the Bank. The Facility replaces the Group's previous facilities of which GBP19.0m remained drawn. The Facility has a five year term ("Borrowing Term") with covenants and interest consistent with the previous bank facilities. The Term Loan amortises on a straight line basis over the Borrowing Term by quarterly instalments. The RCF is repayable in a bullet at the end of the Borrowing Term. The accordion facility increases by the amount paid off the Term Loan, keeping the overall Facility at GBP60.0 million throughout the Borrowing Term. The banking covenants remain similar to the previous banking arrangements, namely: -- Gearing no greater than 2.5 times Adjusted* EBITDA; -- Interest Cover no less than 3 times; and -- Adjusted* EBITDA cover of greater than GBP7.5 million plus 75% of any future acquired company's EBITDA. The existing lending facilities via Bordeaux Acquisition Limited ("Bordeaux"), the Group's 88% owned subsidiary, remain unchanged. Bordeaux owns the trading companies of Deben UK Limited and Oxford Cryosystems Limited . * Adjusted EBITDA excludes adjusting items relating to amortisation of acquired intangible assets, acquisition-related costs, share based payments and hedging of risks materialising after the end of the year. Brad Ormsby, Judges' Group Finance Director, commented: "We are delighted that Lloyds and its Relationship Team have continued to show their long-term desire to stand behind the Group's growth trajectory. This Facility will provide the Group with a substantially larger springboard to continue with the execution of its buy and build growth strategy." | capitalist | |
29/3/2021 09:30 | Judges Scientific (JDG) management team David Cicurel, CEO, Brad Ormsby, FD & Mark Lavelle, COO, present the results for the full year 2020 to analysts followed by Q&A. Overall the group was impacted by CV19, although each company in the group experienced it differently. By the year-end, the group's organic order book had recovered to 14 weeks (2019: 13.2 weeks). There were three acquisitions during the period. Watch the video here: Or listen to the podcast version here: | tomps2 | |
28/3/2021 23:11 | Here is the programme for tonight Programme for the evening 5.00 pm Introduction to our Mello Roadshow 5.05 pm Alun @MrContrarian reviews the Mello BASH companies 5.10 pm Company presentation by Judges Scientific 5.40 pm How to join corporate fundraisings with James Deal, Primary Bid 6.00 pm Company presentation by Filta Group 6.30 pm Leon Boros interviews Peter Harrison from Bioventix 7.00 pm Company presentation by Digital Box 7.30 pm A March results round up with Paul Scott, Gordon @glasshalfull & Alan Charlton 8.00 pm Company presentation by Get Busy 8.30 pm New IPO presentation by Parsley Box introduced by James Deal, Primary Bid 8.50 pm Mello BASH with Alan Charlton, Alex Schlich, Richard Crow and Kevin Taylor Tickets are still available and if you would like one at half price then enter the code MMTADVFN50. | davidosh |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions